Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Apotea

85.48 SEK

-0.88 %

Less than 1K followers

APOTEA

NASDAQ Stockholm

Personal Goods

Consumer Goods & Services

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
-0.88 %
-1.13 %
-11.31 %
-9.95 %
+1.70 %
+1.76 %
-
-
+1.76 %

Apotea is active in the e-commerce sector. The company operates as an online pharmacy. The company sells and supplies a wide range of prescription and over-the-counter medicines, skin and hair care products as well as make-up and various beauty-related products. The company operates in the Swedish domestic market, where the customer base mainly consists of private individuals. Apotea was founded in 2003 and has its headquarters in Stockholm.

Read more
Market cap
9B SEK
Turnover
20.5M SEK
Revenue
6.54B
EBIT %
4.06 %
P/E
40.9
Dividend yield-%
-
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
4/2
2026

Annual report '25

29/4
2026

Interim report Q1'26

26/5
2026

General meeting '26

All
Webcasts
Press releases
ShowingAll content types
Regulatory press release7 hours ago

Finansinspektionen: Flaggningsmeddelande i Apotea AB (publ)

Apotea
Apotea, Webcast, Q3'25
Webcast11/6/2025, 8:30 AM

Apotea, Webcast, Q3'25

Apotea
Regulatory press release11/6/2025, 6:30 AM

Apotea AB (publ) delårsrapport Q3 2025: Framgångsrik produktionsstart i Varberg och fortsatt god lönsamhet

Apotea

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release11/6/2025, 6:30 AM

Apotea AB (publ) Interim report Q3 2025: Successful production launch in Varberg and continued good profitability

Apotea
Press release10/3/2025, 8:00 AM

Inbjudan till Apoteas webcast för det tredje kvartalet 2025

Apotea
Press release10/3/2025, 8:00 AM

Invitation to Apotea’s Q3 2025 webcast

Apotea
Regulatory press release8/22/2025, 6:55 AM

Apotea: Arbetstagarrepresentanter i styrelsen

Apotea
Regulatory press release8/22/2025, 6:55 AM

Apotea: Employee representatives on the Board of Directors

Apotea
Regulatory press release8/8/2025, 7:08 AM

Finansinspektionen: Flaggningsmeddelande i Apotea AB (publ)

Apotea
Regulatory press release8/6/2025, 6:57 AM

Finansinspektionen: Flaggningsmeddelande i Apotea AB (publ)

Apotea
Apotea, Webcast, Q2'25
Webcast7/18/2025, 7:30 AM

Apotea, Webcast, Q2'25

Apotea
Regulatory press release7/18/2025, 5:30 AM

Apotea AB (publ) Interim report Q2 2025: Strengthened profitability and increased demand for prescription products

Apotea
Regulatory press release7/18/2025, 5:30 AM

Apotea AB (publ) delårsrapport Q2 2025: Stärkt lönsamhet och ökad efterfrågan på receptbelagda varor

Apotea
Press release6/18/2025, 6:30 AM

Inbjudan till Apoteas webcast för det andra kvartalet 2025

Apotea
Press release6/18/2025, 6:30 AM

Invitation to Apotea's Q2 2025 webcast

Apotea
Regulatory press release6/13/2025, 11:42 AM

Finansinspektionen: Flaggningsmeddelande i Apotea AB (publ)

Apotea
Regulatory press release6/13/2025, 7:32 AM

Finansinspektionen: Flaggningsmeddelande i Apotea AB (publ)

Apotea
Regulatory press release6/12/2025, 1:21 PM

Finansinspektionen: Flaggningsmeddelande i Apotea AB (publ)

Apotea
Regulatory press release6/4/2025, 2:33 PM

Finansinspektionen: Flaggningsmeddelande i Apotea AB (publ)

Apotea
Regulatory press release6/4/2025, 2:27 PM

Finansinspektionen: Flaggningsmeddelande i Apotea AB (publ)

Apotea
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.